Shenbi Bio was founded in March 2023.familyBased on the plant cell chassis synthetic biotechnology platform,A high-tech enterprise focusing on the research, development and production of gene-edited luminescent plants. We integrated natural luminescent genes through gene editing and successfully cultivatedThe first domestic strainHigh-brightness, stable self-luminous plants, this technology has been expanded to more than 20 plant categories, and a "The world's first dual-gene (TAL tyrosine pathway) pathway patent"The technical system has achieved a breakthrough in the luminous performance of plants.

Based on leading bioluminescence technology, the company is committed toconsumer life、Popular science exhibition、Cultural and tourist attractionsandrural revitalizationIn other fields, we provide sustainable and eco-friendly "bio-lightscape" solutions, and cooperate with a number of institutions to establish a complete capability system from R&D to industrialization.

With the vision of becoming a global leader in bioluminescence technology, Shenbi Biotech continues to explore the application boundaries of light of life and inject warm, safe and sustainable scientific and technological energy into future life.